A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in Germany

NCT07102368 · clinicaltrials.gov ↗

RECRUITING

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammatory Bowel Disease
Colitis, Ulcerative
Crohn's Disease

Sponsor

Janssen-Cilag G.m.b.H